Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

British Journal of Cancer, Published online: 10 January 2024; doi:10.1038/s41416-023-02525-2Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

Source: British Journal of Cancer - January 10, 2024 Category: Cancer & Oncology Authors: Michael D. Hogarty David S. Ziegler Andrea Franson Yueh-Yun Chi Denice Tsao-Wei Kangning Liu Rohan Vemu Eugene W. Gerner Elizabeth Bruckheimer Anasheh Shamirian Beth Hasenauer Frank M. Balis Susan Groshen Murray D. Norris Michelle Haber Julie R. Park Kath Source Type: research